{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:55:56Z","timestamp":1787604956429,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.lansea.2023.100207","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:26:14Z","timestamp":1684218374000},"page":"100207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure"],"prefix":"10.1016","volume":"14","author":[{"given":"Gagandeep","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Lakhkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetanraj","family":"Bhamare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Dharmadhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Narwadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Kanujia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Kapse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwat","family":"Gunale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus S.","family":"Poonawalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lansea.2023.100207_bib2","series-title":"WHO expert consultation on rabies: second report","year":"2013"},{"key":"10.1016\/j.lansea.2023.100207_bib3","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lansea.2023.100207_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.aje.a121323","article-title":"Vaccine production in human diploid cell strains","volume":"94","author":"Plotkin","year":"1971","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.lansea.2023.100207_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/14760584.2017.1294068","article-title":"Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd","volume":"16","author":"Kulkarni","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"24","key":"10.1016\/j.lansea.2023.100207_bib6","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.vaccine.2013.03.050","article-title":"Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers","volume":"31","author":"Kulkarni","year":"2013","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.lansea.2023.100207_bib7","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1016\/j.vaccine.2016.08.005","article-title":"A\u00a0randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes","volume":"34","author":"Bose","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.lansea.2023.100207_bib8","author":"World Health Organization"},{"key":"10.1016\/j.lansea.2023.100207_bib9","first-page":"461","article-title":"On the importance of rabies in Morocco","volume":"42","author":"Noury","year":"1963","journal-title":"Maroc Med"},{"key":"10.1016\/j.lansea.2023.100207_bib10","first-page":"303","article-title":"Treatment of rabid wolf bites in Iran. Present situation","volume":"106","author":"Sabeti","year":"1964","journal-title":"Ann Inst Pasteur (Paris)"},{"key":"10.1016\/j.lansea.2023.100207_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206191","article-title":"Rabies encephalitis in a child: a failure of rabies post exposure prophylaxis?","volume":"2015","author":"Tinsa","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.lansea.2023.100207_bib12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/s41598-020-59109-w","article-title":"Trends and clinico-epidemiological features of human rabies cases in Bangladesh 2006-2018","volume":"10","author":"Ghosh","year":"2020","journal-title":"Sci Rep"},{"issue":"Suppl 4","key":"10.1016\/j.lansea.2023.100207_bib13","first-page":"S766","article-title":"Use of serum and vaccine in combination for prophylaxis following exposure to rabies","volume":"10","author":"Lin","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"19","key":"10.1016\/j.lansea.2023.100207_bib14","doi-asserted-by":"crossref","first-page":"20168","DOI":"10.2807\/ese.17.19.20168-en","article-title":"Fatal case of human rabies imported to Italy from India highlights the importance of adequate post-exposure prophylaxis, October 2011","volume":"17","author":"De Benedictis","year":"2012","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.lansea.2023.100207_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/0255-0857.81786","article-title":"Fatal rabies despite post-exposure prophylaxis","volume":"29","author":"Deshmukh","year":"2011","journal-title":"Indian J Med Microbiol"},{"issue":"1","key":"10.1016\/j.lansea.2023.100207_bib16","first-page":"202","article-title":"Rabies: need for active and passive immunisation","volume":"3","author":"Sangeetha Lakshmi","year":"2014","journal-title":"Int J Med Res Health Sci"},{"issue":"2","key":"10.1016\/j.lansea.2023.100207_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/1817-1745.139328","article-title":"Paralytic rabies following cat scratch and intra-dermal anti-rabies vaccination","volume":"9","author":"Gowda","year":"2014","journal-title":"J\u00a0Pediatr Neurosci"},{"key":"10.1016\/j.lansea.2023.100207_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(89)90003-0","article-title":"Adverse effects of equine rabies immune gobulin","volume":"7","author":"Wilde","year":"1989","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.lansea.2023.100207_bib19","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1016\/j.vaccine.2010.08.034","article-title":"Socioeconomic status is a critical risk factor for human rabies post-exposure prophylaxis","volume":"28","author":"Fang","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.lansea.2023.100207_bib20","first-page":"459","article-title":"Demographics of animal bite victims & management practices in a tertiary care institute in Mumbai, Maharashtra, India","volume":"139","author":"Gogtay","year":"2014","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.lansea.2023.100207_bib21","first-page":"32","article-title":"An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey","volume":"38","author":"Sudarshan","year":"2006","journal-title":"J\u00a0Commun Dis"},{"key":"10.1016\/j.lansea.2023.100207_bib22","first-page":"375","article-title":"Elimination of human rabies in a canine endemic province in Thailand: five-year programme","volume":"81","author":"Kamoltham","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"15","key":"10.1016\/j.lansea.2023.100207_bib23","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","article-title":"Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates","volume":"25","author":"Sloan","year":"2007","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.lansea.2023.100207_bib24","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1016\/j.vaccine.2012.09.027","article-title":"Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults","volume":"30","author":"Gogtay","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.lansea.2023.100207_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/cid\/cix791","article-title":"Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2\/3, randomized, single-blind, noninferiority, controlled study","volume":"66","author":"Gogtay","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.lansea.2023.100207_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.antiviral.2011.06.002","article-title":"Glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates","volume":"91","author":"Wang","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.lansea.2023.100207_bib28","first-page":"201","article-title":"Rabies vaccines: WHO position paper","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lansea.2023.100207_bib29","series-title":"World Health Organization model list of essential medicines \u2013 22nd list, 2021","year":"2021"},{"issue":"1","key":"10.1016\/j.lansea.2023.100207_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","article-title":"Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey","volume":"11","author":"Sudarshan","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.lansea.2023.100207_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.47203\/IJCH.2018.v30i03.004","article-title":"Safety of new indigenous human rabies monoclonal antibody (RMAb) for post exposure prophylaxis","volume":"30","author":"Shivalingaiah","year":"2018","journal-title":"Indian J Community Health"},{"issue":"5","key":"10.1016\/j.lansea.2023.100207_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0264-410X(89)90152-7","article-title":"Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization","volume":"7","author":"Dreesen","year":"1989","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.lansea.2023.100207_bib34","doi-asserted-by":"crossref","first-page":"A94","DOI":"10.1016\/j.vaccine.2018.08.034","article-title":"Introduction of intradermal rabies vaccination - a paradigm shift in improving post-exposure prophylaxis in Asia","volume":"37","author":"Gongal","year":"2019","journal-title":"Vaccine"},{"issue":"Supplement","key":"10.1016\/j.lansea.2023.100207_bib35","first-page":"S37","article-title":"Market mapping and landscape analysis of human rabies biologicals in India","volume":"63","author":"Sudarshan","year":"2019","journal-title":"Indian J Public Health"},{"issue":"1","key":"10.1016\/j.lansea.2023.100207_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1086\/313632","article-title":"Rabies","volume":"30","author":"Plotkin","year":"2000","journal-title":"Clin Infect Dis"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368223000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368223000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:50:39Z","timestamp":1757411439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368223000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":33,"alternative-id":["S2772368223000677"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2023.100207","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2023.100207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100207"}}